Waldencast plc (NASDAQ:WALD) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its holdings in Waldencast plc (NASDAQ:WALD) by 116.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 93,561 shares of the company’s stock after acquiring an additional 50,311 shares during the quarter. JPMorgan Chase & Co. owned 0.08% of Waldencast worth $376,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in WALD. Barclays PLC lifted its stake in Waldencast by 301.4% during the third quarter. Barclays PLC now owns 32,436 shares of the company’s stock valued at $117,000 after purchasing an additional 24,355 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Waldencast during the 4th quarter worth $42,000. Catalina Capital Group LLC grew its holdings in shares of Waldencast by 69.9% in the 4th quarter. Catalina Capital Group LLC now owns 27,102 shares of the company’s stock worth $109,000 after acquiring an additional 11,154 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Waldencast by 16.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 64,895 shares of the company’s stock worth $261,000 after acquiring an additional 9,130 shares during the last quarter. Institutional investors own 41.97% of the company’s stock.

Waldencast Price Performance

Shares of WALD opened at $2.77 on Friday. The company’s 50 day moving average price is $2.91 and its 200 day moving average price is $3.25. Waldencast plc has a 52 week low of $2.31 and a 52 week high of $5.46. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21.

Wall Street Analysts Forecast Growth

WALD has been the subject of a number of recent analyst reports. Alliance Global Partners assumed coverage on Waldencast in a research report on Tuesday, April 22nd. They issued a “buy” rating and a $5.00 price target for the company. Telsey Advisory Group set a $5.00 target price on shares of Waldencast in a report on Thursday, March 20th. DA Davidson restated a “buy” rating and set a $7.50 price target on shares of Waldencast in a report on Wednesday, March 19th. Finally, Industrial Alliance Securities set a $5.00 price objective on shares of Waldencast in a research note on Tuesday, April 22nd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Waldencast currently has an average rating of “Moderate Buy” and an average price target of $5.40.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.